Comparative yield of EBUS-TBNA with EBUS-IFBTLP for diagnosis of mediastinal lymphadenopathy
Therapeutic Advances in Respiratory Disease · 2024-01 · 18
DOI: 10.1177/17534666241282217 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 28.09.2024. Verfasst von Rui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Endoscopic Ultrasound-Guided Fine Needle Aspiration, Lymphadenopathy, Lymph Nodes, Mediastinum. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Patients with mediastinal lymph node enlargement (MLNE) are diagnosed depending on lymph node biopsy. Whereas, how to obtain larger tissue masses from mediastinal lymph nodes and improve the diagnostic yield of the disease remains to be investigated.
Objectives
Aiming to assess the diagnostic value of endobronchial ultrasound-guided intranodal forceps biopsy via transbronchial laser photoablation (EBUS-IFB-TLP) in patients with MLNE.
Design
A prospective, self-controlled study.
Methods
This study was conducted on 67 MLNE patients requiring a lymph node biopsy for diagnosis at the Henan Provincial People’s Hospital and the Fuwai Central China Cardiovascular Hospital in China, from January 2020 to December 2022. Each patient underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA group) and EBUS-IFB-TLP (EBUS-IFB-TLP group) on the same mediastinal lymph node for biopsies. The operation time, diagnostic efficiency, and complication rates of the two biopsy methods were compared.
Results
The number of diagnosed patients in the EBUS-IFB-TLP and the EBUS-TBNA groups was 65 (97.0%) and 57 (85.1%), respectively ( p = 0.021). In the EBUS-IFB-TLP group, 28 cases (96.6%) were diagnosed with lung cancer and were classified into different epithelial types. In the EBUS-TBNA group, there were 27 cases (93.1%) diagnosed with lung cancer, of which 26 (89.7%) were classified into different epithelial types. There were 37 (97.4%) and 30 (78.9%) non-lung cancer patients diagnosed in the EBUS-IFB-TLP and EBUS-TBNA groups, respectively ( p = 0.039), while 27 cases (96.4%) of sarcoidosis in the EBUS-IFB-TLP group and 20 cases (71.4%) of sarcoidosis in the EBUS-TBNA group were diagnosed ( p = 0.016). The percentages of intraoperative mild to moderate bleeding complications were 23.9% (16/67) and 14.9% (10/67) in the EBUS-IFB-TLP and in the EBUS-TBNA groups, respectively ( p = 0.109).
Conclusion
This study demonstrated that EBUS-IFB-TLP could be a feasible and effective method in the diagnosis of patients with MLNE, presenting an analogous safety profile compared with EBUS-TBNA. Further studies are needed to verify the diagnostic performance of EBUS-IFB-TLP for MLNE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Respiratory and Critical Care Medicine, The Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Department of Respiratory and Critical Care Medicine, The Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.
- Department of Respiratory and Critical Care Medicine, The Henan Provincial People's Hospital, Zhengzhou, Henan 450052, China.
- Department of Respiratory and Critical Care Medicine, The Fuwai Central China Cardiovascular Hospital, Zhengzhou 450000, Henan, China.
- Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510145, China.
ORCID-Profile: Rui Zhang
Zitieren
APA
Zhang, R., Zhang, W., Cheng, X., Si, D., Liu, B., Hu, X., Chen, X., & Su, Z. (2024). Comparative yield of EBUS-TBNA with EBUS-IFBTLP for diagnosis of mediastinal lymphadenopathy. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666241282217
Vancouver
Zhang R, Zhang W, Cheng X, Si D, Liu B, Hu X, et al. Comparative yield of EBUS-TBNA with EBUS-IFBTLP for diagnosis of mediastinal lymphadenopathy. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666241282217
BibTeX
@article{Zhang2024,
author = {Zhang, Rui and Zhang, Wenping and Cheng, Xiangsong and Si, Dan and Liu, Bao and Hu, Xingang and Chen, Xianliang and Su, Zhuquan},
title = {Comparative yield of EBUS-TBNA with EBUS-IFBTLP for diagnosis of mediastinal lymphadenopathy},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
volume = {18},
doi = {10.1177/17534666241282217}
}
EUVIMED